vagal blockade
Recently Published Documents


TOTAL DOCUMENTS

85
(FIVE YEARS 1)

H-INDEX

20
(FIVE YEARS 0)

Author(s):  
Timothée Fontolliet ◽  
Aurélien Bringard ◽  
Alessandra Adami ◽  
Nazzareno Fagoni ◽  
Enrico Tam ◽  
...  

Abstract Purpose We tested the vagal withdrawal concept for heart rate (HR) and cardiac output (CO) kinetics upon moderate exercise onset, by analysing the effects of vagal blockade on cardiovascular kinetics in humans. We hypothesized that, under atropine, the φ1 amplitude (A1) for HR would reduce to nil, whereas the A1 for CO would still be positive, due to the sudden increase in stroke volume (SV) at exercise onset. Methods On nine young non-smoking men, during 0–80 W exercise transients of 5-min duration on the cycle ergometer, preceded by 5-min rest, we continuously recorded HR, CO, SV and oxygen uptake ($$ \dot{V} $$ V ˙ O2) upright and supine, in control condition and after full vagal blockade with atropine. Kinetics were analysed with the double exponential model, wherein we computed the amplitudes (A) and time constants (τ) of phase 1 (φ1) and phase 2 (φ2). Results In atropine versus control, A1 for HR was strongly reduced and fell to 0 bpm in seven out of nine subjects for HR was practically suppressed by atropine in them. The A1 for CO was lower in atropine, but not reduced to nil. Thus, SV only determined A1 for CO in atropine. A2 did not differ between control and atropine. No effect on τ1 and τ2 was found. These patterns were independent of posture. Conclusion The results are fully compatible with the tested hypothesis. They provide the first direct demonstration that vagal blockade, while suppressing HR φ1, did not affect φ1 of CO.


2018 ◽  
Vol 315 (3) ◽  
pp. H687-H698 ◽  
Author(s):  
Alexandra M. Williams ◽  
Rob E. Shave ◽  
James M. Coulson ◽  
Harriet White ◽  
Bryn Rosser-Stanford ◽  
...  

Left ventricular (LV) twist mechanics differ between men and women during acute physiological stress, which may be partly mediated by sex differences in autonomic control. While men appear to have greater adrenergic control of LV twist, the potential contribution of vagal modulation to sex differences in LV twist remains unknown. Therefore, the present study examined the role of vagal control on sex differences in LV twist during graded lower body negative pressure (LBNP) and supine cycling. On two separate visits, LV mechanics were assessed using two-dimensional speckle-tracking echocardiography in 18 men (22 ± 2 yr) and 17 women (21 ± 4 yr) during −40- and −60-mmHg LBNP and 25% and 50% of peak supine cycling workload with and without glycopyrrolate (vagal blockade). LV twist was not different at baseline but was greater in women during −60 mmHg in both control (women: 16.0 ± 3.4° and men: 12.9 ± 2.3°, P = 0.004) and glycopyrrolate trials (women: 17.7 ± 5.9° and men: 13.9 ± 3.3°, P < 0.001) due to greater apical rotation during control (women: 11.9 ± 3.6° and men: 7.8 ± 1.5°, P < 0.001) and glycopyrrolate (women: 11.6 ± 4.9° and men: 7.1 ± 3.6°, P = 0.009). These sex differences in LV twist consistently coincided with a greater LV sphericity index (i.e., ellipsoid geometry) in women compared with men. In contrast, LV twist did not differ between the sexes during exercise with or without glycopyrrolate. In conclusion, women have augmented LV twist compared with men during large reductions to preload, even during vagal blockade. As such, differences in vagal control do not appear to contribute to sex differences in the LV twist responses to physiological stress, but they may be related to differences in ventricular geometry. NEW & NOTEWORTHY This is the first study to specifically examine the role of vagal autonomic control on sex-related differences in left ventricular (LV) mechanics. Contrary to our hypothesis, vagal control does not appear to primarily determine sex differences in LV mechanical or hemodynamic responses to acute physiological stress. Instead, differences in LV geometry may be a more important contributor to sex differences in LV mechanics.


ASVIDE ◽  
2017 ◽  
Vol 4 ◽  
pp. 135-135
Author(s):  
Carlos Galvez ◽  
Jose Navarro-Martinez ◽  
Sergio Bolufer ◽  
Julio Sesma ◽  
Francisco Lirio ◽  
...  

2012 ◽  
Vol 113 (12) ◽  
pp. 1810-1820 ◽  
Author(s):  
A. Porta ◽  
P. Castiglioni ◽  
M. Di Rienzo ◽  
V. Bari ◽  
T. Bassani ◽  
...  

It is unclear whether the complexity of the variability of the systolic arterial pressure (SAP) provides complementary information to that of the heart period (HP). The complexity of HP and SAP variabilities was assessed from short beat-to-beat recordings (i.e., 256 cardiac beats). The evaluation was made during a pharmacological protocol that induced vagal blockade with atropine or a sympathetic blockade (beta-adrenergic blockade with propranolol or central sympathetic blockade with clonidine) alone or in combination, during a graded head-up tilt, and in patients with Parkinson's disease (PD) without orthostatic hypotension undergoing orthostatic challenge. Complexity was quantified according to the mean square prediction error (MSPE) derived from univariate autoregressive (AR) and multivariate AR (MAR) models. We found that: 1) MSPEMAR did not provide additional information to that of MSPEAR; 2) SAP variability was less complex than that of HP; 3) because HP complexity was reduced by either vagal blockade or vagal withdrawal induced by head-up tilt and was unaffected by beta-adrenergic blockade, HP was under vagal control; 4) because SAP complexity was increased by central sympathetic blockade and was unmodified by either vagal blockade or vagal withdrawal induced by head-up tilt, SAP was under sympathetic control; 5) SAP complexity was increased in patients with PD; and 6) during orthostatic challenge, the complexity of both HP and SAP variabilities in patients with PD remained high, thus indicating both vagal and sympathetic impairments. Complexity indexes derived from short HP and SAP beat-to-beat series provide complementary information and are helpful in detecting early autonomic dysfunction in patients with PD well before circulatory symptoms become noticeable.


2012 ◽  
Vol 22 (11) ◽  
pp. 1771-1782 ◽  
Author(s):  
Michael G. Sarr ◽  
◽  
Charles J. Billington ◽  
Roy Brancatisano ◽  
Anthony Brancatisano ◽  
...  

2009 ◽  
Vol 5 (3) ◽  
pp. S48-S49
Author(s):  
Miguel F. Herrera ◽  
Roy Brancatisano ◽  
Ulrich Keller ◽  
Baard Kulseng ◽  
James Toouli ◽  
...  

2009 ◽  
Vol 5 (3) ◽  
pp. S51-S52
Author(s):  
James Toouli ◽  
Roy Brancatisano ◽  
Ulrich Keller ◽  
Baard Kulseng ◽  
Anthony Brancatisano ◽  
...  

2006 ◽  
Vol 156 (1-2) ◽  
pp. 71-75 ◽  
Author(s):  
Can Zheng ◽  
Toru Kawada ◽  
Meihua Li ◽  
Takayuki Sato ◽  
Kenji Sunagawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document